Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard of Care (SOC) for Acute Myeloid Leukemia (AML) in Canada

May 1, 2018, 00:00
10.1016/j.jval.2018.04.180
https://www.valueinhealthjournal.com/article/S1098-3015(18)30480-7/fulltext
Title : Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard of Care (SOC) for Acute Myeloid Leukemia (AML) in Canada
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)30480-7&doi=10.1016/j.jval.2018.04.180
First page :
Section Title :
Open access? : No
Section Order : 1024
Categories :
Tags :
Regions :
ViH Article Tags :